The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Hereditary Cancer Predisposition Syndromes
Abstract
Cancer genetics is increasingly becoming integrated into the practice of modern medical oncology. The ability to distinguish a growing proportion of the 5% to 10% of all cancers that develop in individuals who have inherited a genetic mutation conferring heightened susceptibility to specific cancers may permit targeted efforts in cancer surveillance and prevention. While these individuals comprise a small proportion of the overall burden of cancer, strategies successful in reducing their remarkable cancer risks may be generalizable to the broader population. In this review, we highlight the most common hereditary cancer syndromes, most attributable to genes inherited in an autosomal dominant manner with incomplete penetrance, and a number of rare syndromes in which particular progress has been made. The prevalence, penetrance, tumor spectrum, and underlying genetic defects are discussed and summarized in a large table in which a more comprehensive enumeration of syndromes is provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873
Self-citationClues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
VASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Identification of FAP Locus Genes from Chromosome 5q21
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,355
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Lynch, H. T., & de la Chapelle, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012242 · Cited by 2,203
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
Sathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
Johnson, R. L., Rothman, A. L., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A. G., Myers, R. M., Cox, D. R., Epstein, E. H., et al. (1996) · Science · doi:10.1126/science.272.5268.1668 · Cited by 1,857
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13643-4 · Cited by 1,600
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms: A Familial Syndrome?
LI, F. P., & FRAUMENI, J. F. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-4-747 · Cited by 1,509
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Self-citationGerm-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,367
Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70168-5 · Cited by 1,337
A cancer family syndrome in twenty-four kindreds.
Li, F. P., Fraumeni, J. F., Mulvihill, J. J., Blattner, W. A., Dreyfus, M., Tucker, M., & Miller, R. (1988) · PubMed · Cited by 1,293
Cancer risk in mutation carriers of DNA-mismatch-repair genes
Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Self-citationInteraction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Biallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R., Henson, D. E., Srivastava, S., Jass, J. R., Khan, P. M., Lynch, H., Smyrk, T., Perucho, M., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1758 · Cited by 1,137
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D.-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,072
Multiple Nevoid Basal-Cell Epithelioma, Jaw Cysts and Bifid Rib: A Syndrome
Gorlin, R. J., & Goltz, R. W. (1960) · New England Journal of Medicine · doi:10.1056/nejm196005052621803 · Cited by 1,029
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318787 · Cited by 986
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation
Meijers-Heijboer, H., van Geel, B., van Putten, W. L. J., Henzen-Logmans, S. C., Seynaeve, C., Menke-Pluymers, M. B. E., Bartels, C. C. M., Verhoog, L. C., van den Ouweland, A. M. W., Niermeijer, M. F., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450301 · Cited by 973
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients
Liu, B., Parsons, R., Papadopoulos, N., Nicolaides, N. C., Lynch, H. T., Watson, P., Jass, J. R., Dunlop, M., Wyllie, A., Peltomäki, P., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-169 · Cited by 945
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
Self-citationPolygenic susceptibility to breast cancer and implications for prevention
Pharoah, P. D. P., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., & Ponder, B. A. J. (2002) · Nature Genetics · doi:10.1038/ng853 · Cited by 899
Neumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893
Nevoid Basal-Cell Carcinoma Syndrome
GORLIN, R. J. (1987) · Medicine · doi:10.1097/00005792-198703000-00002 · Cited by 883
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham, J. M., Christensen, E. R., Tester, D. J., Kim, C. Y., Roche, P. C., Burgart, L. J., & Thibodeau, S. N. (1998) · PubMed · Cited by 863
Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations in MYH
Sieber, O. M., Lipton, L., Crabtree, M., Heinimann, K., Fidalgo, P., Phillips, R. K. S., Bisgaard, M.-L., Orntoft, T. F., Aaltonen, L. A., Hodgson, S. V., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025283 · Cited by 862
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818
Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors
Lindor, N. M., Burgart, L. J., Leontovich, O. N., Goldberg, R. M., Cunningham, J. M., Sargent, D. J., Walsh-Vockley, C., Petersen, G. M., Walsh, M. D., Leggett, B., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1043 · Cited by 817
Frank, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1480 · Cited by 812
Veronesi, U. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04394-3 · Cited by 804
Familial adenomatous polyposis
Galiatsatos, P., & Foulkes, W. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00375.x · Cited by 757
(2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.189 · Cited by 751
Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743
Extracolonic cancer in hereditary nonpolyposis colorectal cancer
Watson, P., & Lynch, H. T. (1993) · Cancer · doi:10.1002/1097-0142(19930201)71:3<677::aid-cncr2820710305>3.0.co;2-# · Cited by 738
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
Laken, S. J., Petersen, G. M., Gruber, S. B., Oddoux, C., Ostrer, H., Giardiello, F. M., Hamilton, S. R., Hampel, H., Markowitz, A., Klimstra, D., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-79 · Cited by 683
Self-citationProspective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds
Klein, A. P., Brune, K. A., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J. A., Griffin, C., Cameron, J. L., Yeo, C. J., Kern, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3823 · Cited by 678
Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16INK4Mutations
Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 622
Alleles of the APC gene: An attenuated form of familial polyposis
Spirio, L., Olschwang, S., Groden, J., Robertson, M., Samowitz, W., Joslyn, G., Gelbert, L., Thliveris, A., Carlson, M., Otterud, B., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90538-2 · Cited by 622
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Kutler, D. I., Singh, B., Satagopan, J., Batish, S. D., Berwick, M., Giampietro, P. F., Hanenberg, H., & Auerbach, A. D. (2003) · Blood · doi:10.1182/blood-2002-07-2170 · Cited by 618
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
Pacak, K., Linehan, W. M., Eisenhofer, G., Walther, M. M., & Goldstein, D. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-4-200102200-00016 · Cited by 618
Oral Contraceptives and the Risk of Hereditary Ovarian Cancer
Narod, S. A., Risch, H., Moslehi, R., Dørum, A., Neuhausen, S., Olsson, H., Provencher, D., Radice, P., Evans, G., Bishop, S., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390702 · Cited by 615
Marsh, D. J., Kum, J. B., Lunetta, K. L., Bennett, M. J., Gorlin, R. J., Ahmed, S. F., Bodurtha, J., Crowe, C., Curtis, M. A., Dasouki, M., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1461 · Cited by 612
Ingles, S. A., Ross, R. K., Yu, M. C., Haile, R. W., Irvine, R. A., La Pera, G., & Coetzee, G. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.2.166 · Cited by 583
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma
Eng, C., Li, F. P., Abramson, D. H., Ellsworth, R. M., Wong, F. L., Goldman, M. B., Seddon, J., Tarbell, N., & Boice, J. D. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.14.1121 · Cited by 568
Will the real Cowden syndrome please stand up: revised diagnostic criteria
Eng, C. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.11.828 · Cited by 566
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
Narod, S. A., Brunet, J.-S., Ghadirian, P., Robson, M., Heimdal, K., Neuhausen, S. L., Stoppa-Lyonnet, D., Lerman, C., Pasini, B., de los Rios, P., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03258-x · Cited by 543
Clinicopathologic Features of <EMPH TYPE="ITAL">BRCA</EMPH>-Linked and Sporadic Ovarian Cancer
Boyd, J. (2000) · JAMA · doi:10.1001/jama.283.17.2260 · Cited by 536
Maher, E. R., & Kaelin, W. G. (1997) · Medicine · doi:10.1097/00005792-199711000-00001 · Cited by 528
Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22
Cannon-Albright, L. A., Goldgar, D. E., Meyer, L. J., Lewis, C. M., Anderson, D. E., Fountain, J. W., Hegi, M. E., Wiseman, R. W., Petty, E. M., Bale, A. E., et al. (1992) · Science · doi:10.1126/science.1439824 · Cited by 524
Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer
Järvinen, H. J., Mecklin, J.-P., & Sistonen, P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90688-6 · Cited by 511
Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
Bishop, D. T. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.894 · Cited by 509
Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1730 · Cited by 484
BRCA2 germline mutations in familial pancreatic carcinoma
Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.214 · Cited by 480
Phillips, R. K. S., Wallace, M. H., Lynch, P. M., Hawk, E., Gordon, G. B., Saunders, B. P., Wakabayashi, N., Shen, Y., Zimmerman, S., Godio, L., et al. (2002) · Gut · doi:10.1136/gut.50.6.857 · Cited by 441
Murphy, K. M., Brune, K. A., Griffin, C. A., Sollenberger, J. E., Petersen, G. M., Bansal, R. K., Hruban, R. H., & Kern, S. E. (2002) · PubMed · Cited by 435
Improved survival in women with BRCA‐associated ovarian carcinoma
Cass, I., Baldwin, R. L., Varkey, T., Moslehi, R., Narod, S. A., & Karlan, B. Y. (2003) · Cancer · doi:10.1002/cncr.11310 · Cited by 433
GermlineTP53 mutations and Li-Fraumeni syndrome
Varley, J. M. (2003) · Human Mutation · doi:10.1002/humu.10185 · Cited by 430
Early Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations
Huntsman, D. D., Carneiro, F., Lewis, F. R., MacLeod, P., Hayashi, A., Monaghan, K. G., Maung, R., Seruca, R., Jackson, C. E., & Caldas, C. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442504 · Cited by 416
Primary Chemoprevention of Familial Adenomatous Polyposis with Sulindac
Giardiello, F. M., Yang, V. W., Hylind, L. M., Krush, A. J., Petersen, G. M., Trimbath, J. D., Piantadosi, S., Garrett, E., Geiman, D. E., Hubbard, W., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012015 · Cited by 410
Wijnen, J. T., Vasen, H. F. A., Khan, P. M., Zwinderman, A. H., van der Klift, H., Mulder, A., Tops, C., Møller, P., Fodde, R., Menko, F., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390804 · Cited by 396
Modan, B., Hartge, P., Hirsh-Yechezkel, G., Chetrit, A., Lubin, F., Beller, U., Ben-Baruch, G., Fishman, A., Menczer, J., Struewing, J. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450401 · Cited by 385
Whittemore, A. S., Gong, G. D., & Itnyre, J. (1997) · PubMed · Cited by 383
Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Narod, S. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.23.1773 · Cited by 380
Brooks-Wilson, A. R., Kaurah, P., Suriano, G., Leach, S., Senz, J., Grehan, N., Butterfield, Y. S. N., Jeyes, J., Schinas, J., Bacani, J., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018275 · Cited by 361
Li-Fraumeni syndrome – a molecular and clinical review
Varley, J., Evans, D., & Birch, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.328 · Cited by 358
Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
Nichols, K. E., Malkin, D. M., Garber, J. E., Fraumeni, J. F., & Li, F. P. (2001) · PubMed · Cited by 354
Self-citationEisenhofer, G., Lenders, J. W. M., Linehan, W. M., Walther, M. M., Goldstein, D. S., & Keiser, H. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402404 · Cited by 349
AGA technical review on hereditary colorectal cancer and genetic testing
(2001) · Gastroenterology · doi:10.1053/gast.2001.25581 · Cited by 347
Vasen, H. F. A., Gruis, N. A., Frants, R. R., van der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<809::aid-ijc8>3.0.co;2-u · Cited by 347
Borg, A., Sandberg, T., Nilsson, K., Johannsson, O., Klinker, M., Masback, A., Westerdahl, J., Olsson, H., & Ingvar, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1260 · Cited by 345
Cunningham, J. M., Kim, C.-Y., Christensen, E. R., Tester, D. J., Parc, Y., Burgart, L. J., Halling, K. C., McDonnell, S. K., Schaid, D. J., Walsh Vockley, C., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/323658 · Cited by 344
Acquired Precursors of Cutaneous Malignant Melanoma: The Familial Dysplastic Nevus Syndrome
Greene, M. H., Clark, W. H., Tucker, M. A., Elder, D. E., Kraemer, K. H., Guerry, D., Witmer, W. K., Thompson, J., Matozzo, I., & Fraser, M. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501103120205 · Cited by 336
Mapping the Gene for Hereditary Cutaneous Malignant Melanoma–Dysplastic Nevus to Chromosome Lp
Bale, S. J., Dracopoli, N. C., Tucker, M. A., Clark, W. H., Fraser, M. C., Stanger, B. Z., Green, P., Donis-Keller, H., Housman, D. E., & Greene, M. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202102 · Cited by 315
Lifetime Risks of Common Cancers Among Retinoblastoma Survivors
Fletcher, O., Easton, D., Anderson, K., Gilham, C., Jay, M., & Peto, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh058 · Cited by 312
Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with Sarcoma
Toguchida, J., Yamaguchi, T., Dayton, S. H., Beaughamp, R. L., Herrera, G. E., Ishizaki, K., Yamamuro, T., Meyers, P. A., Little, J. B., Sasaki, M. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262001 · Cited by 307
Study of a single BRCA2 mutation with high carrier frequency in a small population.
Thorlacius, S., Sigurðsson, S., Bjarnadóttir, H., Ólafsdóttir, G. H., Jonasson, J. G., Tryggvadóttír, L., Tulinius, H., & Je, E. (1997) · Europe PMC (PubMed Central) · Cited by 294
Guilford, P. J., Hopkins, J. B. W., Grady, W. M., Markowitz, S. D., Willis, J., Lynch, H., Rajput, A., Wiesner, G. L., Lindor, N. M., Burgart, L. J., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)14:3<249::aid-humu8>3.0.co;2-9 · Cited by 283
Wicking, C., Shanley, S., Smyth, I., Gillies, S. A., Negus, K., Graham, S., Suthers, G., Haites, N. E., Edwards, M. J., Wainwright, B. J., et al. (1997) · Europe PMC (PubMed Central) · Cited by 276
Fanconi anemia gene mutations in young-onset pancreatic cancer.
van der Heijden, M. S., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2003) · PubMed · Cited by 264
WALTHER, M. M., REITER, R., KEISER, H. R., CHOYKE, P. L., VENZON, D., HURLEY, K., GNARRA, J. R., REYNOLDS, J. C., GLENN, G. M., ZBAR, B., et al. (1999) · Journal of Urology · doi:10.1097/00005392-199909010-00004 · Cited by 255
Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers
Lakhani, S. R., Manek, S., Penault-Llorca, F., Flanagan, A., Arnout, L., Merrett, S., McGuffog, L., Steele, D., Devilee, P., Klijn, J. G. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1029-3 · Cited by 252
Pheochromocytoma: The expanding genetic differential diagnosis.
Bryant, J., Farmer, J., Kessler, L. J., Townsend, R. R., & Nathanson, K. L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg024 · Cited by 250
Lal, G., Liu, G., Schmocker, B., Kaurah, P., Özçelik, H., Narod, S. A., Redston, M. S., & Gallinger, S. (2000) · PubMed · Cited by 231
Hereditary Prostate Cancer: Clinical Aspects
Bratt, O. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64541-7 · Cited by 229
Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome)
Vasen, H. F. A., Nagengast, F. M., & Meera Khan, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91016-6 · Cited by 224
An update of HNPCC (Lynch syndrome)
Lynch, H. T., Smyrk, T., & Lynch, J. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00290-7 · Cited by 223
Wagner, J. E. (2004) · Blood · doi:10.1182/blood-2003-09-3138 · Cited by 214
Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome
REIMER, R. R. (1978) · JAMA · doi:10.1001/jama.239.8.744 · Cited by 212
Bertario, L., Russo, A., Sala, P., Varesco, L., Giarola, M., Mondini, P., Pierotti, M., Spinelli, P., & Radice, P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.118 · Cited by 210
Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations
Levine, D. A., Argenta, P. A., Yee, C. J., Marshall, D. S., Olvera, N., Bogomolniy, F., Rahaman, J. A., Robson, M. E., Offit, K., Barakat, R. R., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.131 · Cited by 206
Self-citationRetinoblastoma: Revisiting the model prototype of inherited cancer
Lohmann, D. R., & Gallie, B. L. (2004) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30024 · Cited by 203
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history
Lalloo, F., Varley, J., Ellis, D., Moran, A., O'Dair, L., Pharoah, P., & Evans, D. G. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12856-5 · Cited by 202
Shared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia
Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S. D., Diotti, R., Schneider, H., Deffenbaugh, A., Scholl, T., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg072 · Cited by 201
Self-citationOn the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance
Begg, C. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1221 · Cited by 201
Birch, J. M., Blair, V., Kelsey, A. M., Evans, D. G., Harris, M., Tricker, K. J., & Varley, J. M. (1998) · Oncogene · doi:10.1038/sj.onc.1202033 · Cited by 200
Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis
Burt, R. W., Leppert, M. F., Slattery, M. L., Samowitz, W. S., Spirio, L. N., Kerber, R. A., Kuwada, S. K., Neklason, D. W., DiSario, J. A., Lyon, E., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.003 · Cited by 194
Male breast cancer in Cowden syndrome patients with germline PTEN mutations
Fackenthal, J. D., Marsh, D. J., Richardson, A.-L., Cummings, S. A., Eng, C., Robinson, B. G., & Olopade, O. I. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.3.159 · Cited by 190
Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Struewing, J. P., Watson, P., Easton, D., Ponder, B. A. J., Lynch, H. T., & Tucker, M. A. (1995) · PubMed · Cited by 184
The pressure rises: update on the genetics of phaeochromocytoma
Maher, E. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2347 · Cited by 176
Precursor Lesions in Familial Melanoma: A New Genetic Preneoplastic Syndrome
Reimer, R. R. (1978) · JAMA · doi:10.1001/jama.1978.03280350068019 · Cited by 171
Graziano, F., Humar, B., & Guilford, P. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg486 · Cited by 168
Attenuated Familial Adenomatous Polyposis: An Evolving and Poorly Understood Entity
Church, J. M., Hernegger, G. S., Moore, H. G., & Guillem, J. G. (2002) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6127-y · Cited by 167
BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews
Kirchhoff, T., Kauff, N. D., Mitra, N., Nafa, K., Huang, H., Palmer, C., Gulati, T., Wadsworth, E., Donat, S., Robson, M. E., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0604 · Cited by 165
Self-citationParc, Y. R., Olschwang, S., Desaint, B., Schmitt, G., Parc, R. G., & Tiret, E. (2001) · Annals of Surgery · doi:10.1097/00000658-200103000-00009 · Cited by 162
Hensen, E. F., Jordanova, E. S., van Minderhout, I. J. H. M., Hogendoorn, P. C. W., Taschner, P. E. M., van der Mey, A. G. L., Devilee, P., & Cornelisse, C. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207591 · Cited by 157
Unger, M. A., Nathanson, K. L., Calzone, K., Antin-Ozerkis, D. E., Shih, H. A., Martin, A., Lenoir, G., Mazoyer, S., & Weber, B. L. (2000) · The American Journal of Human Genetics · doi:10.1086/303076 · Cited by 157
Constitutional RB1-Gene Mutations in Patients with Isolated Unilateral Retinoblastoma
Lohmann, D. R., Gerick, M., Brandt, B., Oelschläger, U., Lorenz, B., Passarge, E., & Horsthemke, B. (1997) · The American Journal of Human Genetics · doi:10.1086/514845 · Cited by 154
Hruban, R. H., Petersen, G. M., Goggins, M., Tersmette, A. C., Offerhaus, G. J. A., Falatko, F., Yeo, C. J., & Kern, S. E. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s69 · Cited by 134
Cowan, R. A., Hoban, P. R., Kelsey, A. M., et al. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.354 · Cited by 134
Evidence for a major gene influencing risk of pancreatic cancer
Klein, A. P., Beaty, T. H., Wilson, J., Brune, K. A., Hruban, R. H., & Petersen, G. M. (2002) · Genetic Epidemiology · doi:10.1002/gepi.1102 · Cited by 130
Preimplantation genetic diagnosis for cancer predisposition
Rechitsky, S., Verlinsky, O., Chistokhina, A., Sharapova, T., Ozen, S., Masciangelo, C., Kuliev, A., & Verlinsky, Y. (2002) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61617-3 · Cited by 130
Surgical management of hereditary pheochromocytoma1
Yip, L., Lee, J. E., Shapiro, S. E., Waguespack, S. G., Sherman, S. I., Hoff, A. O., Gagel, R. F., Arens, J. F., & Evans, D. B. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2003.12.001 · Cited by 127
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.
Liu, T., Yan, H., Kuismanen, S. A., Percesepe, A., Bisgaard, M. L., Pedroni, M., Benatti, P., Kinzler, K. W., Vogelstein, B., de Leòn, M. P., et al. (2001) · PubMed · Cited by 126
Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL
Woodward, E. R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1051 · Cited by 125
A New Susceptibility Locus for Autosomal Dominant Pancreatic Cancer Maps to Chromosome 4q32-34
Eberle, M. A., Pfützer, R. H., Pogue-Geile, K. L., Bronner, M. P., Crispin, D. A., Kimmey, M. B., Duerr, R. H., Kruglyak, L., Whitcomb, D. C., & Brentnall, T. A. (2002) · The American Journal of Human Genetics · doi:10.1086/339692 · Cited by 124
Molecular Basis of Low-Penetrance Retinoblastoma
Harbour, J. W. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.11.1699 · Cited by 123
Vasen, H. F. A. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.12.2717 · Cited by 120
Genetic and environmental interactions
Strong, L. C. (1977) · Cancer · Cited by 119
Goldstein, A. M., Dracopoli, N. C., Ho, E. C., Fraser, M. C., Kearns, K. S., Bale, S. J., McBride, O. W., Clark, W. H., & Tucker, M. A. (1993) · Europe PMC (PubMed Central) · Cited by 109
Primary Breast Cancer After Prophylactic Mastectomy
Ziegler, L. D., & Kroll, S. S. (1991) · American Journal of Clinical Oncology · doi:10.1097/00000421-199110000-00018 · Cited by 103
Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma.
Noorani, H. Z., Khan, H. N., Gallie, B. L., & Detsky, A. S. (1996) · PubMed Central · Cited by 102
Kauff, N. D., Pérez‐Segura, P., Robson, M. E., Scheuer, L., Siegel, B., Schluger, A. E., Rapaport, B., Frank, T. S., Nafa, K., Ellis, N. A., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.611 · Cited by 94
Self-citationPhillips, K., Andrulis, I. L., & Goodwin, P. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3653 · Cited by 93
Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM).
Cannon‐Albright, L., Meyer, L. J., Goldgar, D. E., Lewis, C. M., McWhorter, W. P., Jost, M., Harrison, D., Anderson, D. E., Zone, J. J., & Skolnick, M. H. (1994) · PubMed · Cited by 86
Multiple endocrine neoplasia type 1 (MEN1)
Pang, J. T., & Thakker, R. V. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00387-k · Cited by 77
Hereditary Retinoblastoma, Lipoma, and Second Primary Cancers
Li, F. P., Abramson, D. H., Tarone, R. E., Kleinerman, R. A., Fraumeni, J. F., & Boice, J. D. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.1.83 · Cited by 74
Marcus, D. M., Brooks, S. E., Leff, G., Mccormick, R., Thompson, T., Anfinson, S., Lasudry, J., & Albert, D. M. (1998) · Survey of Ophthalmology · doi:10.1016/s0039-6257(98)00019-8 · Cited by 72
A Screening Study of Prostate Cancer in High Risk Families
McWhorter, W. P., Hernandez, A. D., Meikle, A. W., Terreros, D. A., Smith, J. A. J., Skolnick, M. H., Cannon‐Albright, L., & Eyre, H. J. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)36733-2 · Cited by 69
Clinical germline genetic testing for melanoma.
Hansen, C. B., Wadge, L. M., Lowstuter, K. J., Boucher, K. M., & Leachman, S. A. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01469-x · Cited by 66
NCCN Practice Guidelines for Colorectal Cancer.
Benson, A. B., Choti, M. A., Cohen, A. M., Doroshow, J. H., Fuchs, C., Kiel, K. D., Martin, E., McGinn, C. J., Petrelli, N. J., Posey, J. A., et al. (2000) · PubMed · Cited by 58
Breast MRI for Women With Hereditary Cancer Risk
Robson, M. E., & Offit, K. (2004) · JAMA · doi:10.1001/jama.292.11.1368 · Cited by 55
Self-citationPsychosocial aspects of cancer genetics: Women at high risk for breast and ovarian cancer
Kash, K. M., Ortega-Verdejo, K., Dabney, M. K., Holland, J. C., Miller, D. G., & Osborne, M. P. (2000) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(200006)18:4<287::aid-ssu3>3.0.co;2-5 · Cited by 50
Eng, C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04337.x · Cited by 44
Familial Pancreatic Cancer: Where Are We in 2003?
Petersen, G. M., & Hruban, R. H. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.180 · Cited by 44
TP53, hChk2, and the Li-Fraumeni Syndrome
Varley, J. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:117 · Cited by 43
BRCA1and Medullary Breast Cancer
Eisinger, F. (1998) · JAMA · doi:10.1001/jama.280.14.1227 · Cited by 32
Eeles, R. (2000) · Breast Cancer Research · doi:10.1186/bcr70 · Cited by 32
The Power of Genetics to Target Surgical Prevention
Weitzel, J. N., & McCahill, L. E. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442511 · Cited by 18
General Keynote: Hereditary Cancer: Lessons from Li–Fraumeni Syndrome
Strong, L. C. (2003) · Gynecologic Oncology · doi:10.1006/gyno.2002.6673 · Cited by 17
Cited by
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi326 · Cited by 1,127
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Lee, C. H., Dershaw, D. D., Kopans, D., Evans, P., Monsees, B., Monticciolo, D., Brenner, R. J., Bassett, L., Berg, W., Feig, S., et al. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.09.022 · Cited by 809
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work
Gillies, R. J., Verduzco, D., & Gatenby, R. A. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3298 · Cited by 684
Metadata
- Authors
- Garber, J. E., & Offit, K.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-01-10
- Volume
- 23
- Issue
- 2
- Pages
- 276-292
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2089155477
- Cited by
- 697
- References
- 171
- FWCI
- 17.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.